Profile data is unavailable for this security.
About the company
Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Company’s segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Company’s subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.
- Revenue in AUD (TTM)7.21m
- Net income in AUD-5.93m
- Incorporated2016
- Employees--
- LocationEpsilon Healthcare LtdSuite 4102Level 41, 264-278 George StreetSYDNEY 2000AustraliaAUS
- Phone+61 29251-7177
- Websitehttps://epsilonhealthcare.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bod Science Ltd | 3.32m | -7.95m | 4.26m | -- | -- | -- | -- | 1.28 | -0.0557 | -0.0557 | 0.0235 | -0.0046 | 0.7533 | 2.42 | 8.05 | -- | -180.40 | -94.62 | -465.66 | -145.77 | 69.23 | 47.08 | -239.47 | -129.48 | 0.8319 | -- | 3.71 | -- | -34.70 | 23.20 | -47.10 | -- | 8.23 | -- |
| Cambium Bio Ltd | -28.22k | -366.01k | 5.36m | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | -0.00009 | -0.0036 | -0.039 | -- | -- | -- | -50.58 | -49.44 | -- | -292.47 | -- | -- | -- | -118.34 | -- | -- | -- | -- | -- | -- | 60.86 | -- | -- | -- |
| Invex Therapeutics Ltd | 837.95k | -6.01m | 5.86m | -- | -- | 1.11 | -- | 7.00 | -0.08 | -0.08 | 0.0112 | 0.0705 | 0.0521 | -- | 2.79 | -- | -37.38 | -- | -40.06 | -- | -- | -- | -717.76 | -- | -- | -- | 0.00 | -- | 379.22 | -- | -96.04 | -- | -- | -- |
| Neuroscientific Biopharmaceuticals Ltd | 3.94m | 761.17k | 6.51m | -- | 8.33 | 1.71 | 7.83 | 1.65 | 0.0054 | 0.0054 | 0.0273 | 0.0264 | 1.02 | -- | 76.13 | -- | 19.64 | -55.72 | 23.29 | -60.89 | -- | -- | 19.34 | -301.54 | -- | 54.64 | 0.00 | -- | 7,292.97 | 179.97 | 89.76 | -- | -- | -- |
| Island Pharmaceuticals Ltd | 10.28k | -2.37m | 6.71m | -- | -- | 8.46 | -- | 653.11 | -0.026 | -0.026 | 0.0001 | 0.007 | 0.0038 | -- | 0.0318 | -- | -88.77 | -- | -134.02 | -- | -- | -- | -23,100.68 | -- | -- | -- | 0.4433 | -- | -- | -- | -8.58 | -- | -- | -- |
| Calmer Co International Ltd | 2.46m | -4.50m | 6.80m | -- | -- | -- | -- | 2.76 | -0.0091 | -0.0091 | 0.0042 | -0.0005 | 0.655 | 1.34 | 9.62 | -- | -119.81 | -139.15 | -231.33 | -198.55 | 36.03 | 30.26 | -182.94 | -388.81 | 0.482 | -9.36 | 1.22 | -- | -13.00 | 239.43 | 11.40 | -- | -- | -- |
| Epsilon Healthcare Ltd | 7.21m | -5.93m | 7.21m | -- | -- | 0.7868 | -- | 0.9994 | -0.0198 | -0.0198 | 0.0241 | 0.0305 | 0.3839 | 17.94 | 2.73 | -- | -31.54 | -35.68 | -46.30 | -41.11 | 37.99 | 26.88 | -82.17 | -197.56 | 0.5237 | -9.28 | 0.2329 | -- | 29.36 | 30.99 | -43.77 | -- | 8.14 | -- |
| Zelira Therapeutics Ltd | 1.62m | -36.43m | 7.60m | 8.00 | -- | -- | -- | 4.69 | -3.23 | -3.23 | 0.148 | -0.2063 | 0.0848 | 0.185 | 3.55 | -- | -193.14 | -27.71 | -243.04 | -28.81 | 82.28 | -- | -2,278.17 | -508.48 | 0.1488 | -22.80 | -- | -- | -80.95 | -0.3635 | 53.35 | -- | -- | -- |
| Anatara Lifesciences Ltd | 0.00 | -1.75m | 7.84m | -- | -- | 5.43 | -- | -- | -0.014 | -0.014 | 0.00 | 0.0076 | 0.00 | -- | -- | -- | -103.15 | -59.64 | -115.72 | -66.52 | -- | -- | -- | -1,927.05 | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -40.49 | -- |
| Terragen Holdings Ltd | 2.60m | -2.53m | 8.86m | -- | -- | 1.30 | -- | 3.40 | -0.0099 | -0.0099 | 0.0101 | 0.0185 | 0.3364 | 0.5758 | 11.93 | -- | -32.71 | -43.86 | -39.59 | -50.11 | 96.61 | 87.96 | -97.24 | -173.81 | 5.79 | -347.50 | 0.0587 | -- | 13.67 | 31.22 | 40.19 | -- | -12.30 | -- |
| Avecho Biotechnology Ltd | 473.55k | -3.44m | 9.51m | 29.00 | -- | 1.49 | -- | 20.08 | -0.0016 | -0.0016 | 0.0002 | 0.002 | 0.0888 | 2.07 | 0.5132 | -- | -64.45 | -47.08 | -75.73 | -55.25 | -9.25 | 78.67 | -725.70 | -156.43 | 8.19 | -- | 0.0267 | -- | -58.07 | -19.42 | -46.71 | -- | -- | -- |
| TrivarX Ltd | 20.81k | -3.74m | 9.82m | 4.00 | -- | 1.17 | -- | 471.69 | -0.0182 | -0.0182 | 0.00009 | 0.0249 | 0.0023 | -- | -- | -- | -42.02 | -41.56 | -47.15 | -50.51 | 100.00 | 92.74 | -17,949.78 | -334.16 | -- | -147.21 | 0.0072 | -- | -4.69 | -18.06 | 75.85 | -- | -- | -- |
| Althea Group Holdings Ltd | 28.70m | -20.99m | 10.54m | -- | -- | 0.6874 | -- | 0.3672 | -0.059 | -0.059 | 0.0796 | 0.0378 | 0.6181 | 2.47 | 5.53 | -- | -45.22 | -31.09 | -66.73 | -36.32 | 54.64 | 50.76 | -73.15 | -101.39 | 0.4899 | -46.55 | 0.2756 | -- | 22.43 | 335.18 | -13.21 | -- | -- | -- |
